Ameet Mallik wraps a $435M com­mer­cial deal short­ly af­ter tak­ing helm at ADC

Two months in as the new CEO of the Eu­ro­pean-based biotech ADC Ther­a­peu­tics, Ameet Mallik can take cred­it for a sub­stan­tial re­gion­al li­cens­ing pact cov­er­ing …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER